SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-20-030296
Filing Date
2020-12-02
Accepted
2020-12-02 16:31:19
Documents
1
Period of Report
2020-12-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6221
  Complete submission text file 0001127602-20-030296.txt   7540
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address
Francois Cedric (Reporting) CIK: 0001658080 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 201364156